Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 145,830 shares at $132.98 ($19.5M) on 2023-05-04, disclosed to the SEC on 2023-05-05.
Scheduled sale ($19.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.60 | 13,570 | $1.8M | 9.1% |
| 2 | $131.54 | 21,854 | $2.9M | 14.7% |
| 3 | $131.54 | 21,854 | $2.9M | 14.7% |
| 4 | $132.12 | 4,576 | $605K | 3.1% |
| 5 | $132.12 | 4,576 | $605K | 3.1% |
| 6 | $132.98 | 600 |
| $80K |
| 0.4% |
| 7 | $134.32 | 2,846 | $382K | 2.0% |
| 8 | $134.32 | 2,846 | $382K | 2.0% |
| 9 | $135.06 | 13,468 | $1.8M | 9.3% |
| 10 | $135.06 | 13,468 | $1.8M | 9.3% |
| 11 | $136.01 | 16,552 | $2.3M | 11.5% |
| 12 | $136.01 | 16,552 | $2.3M | 11.5% |
| 13 | $136.97 | 5,427 | $743K | 3.8% |
| 14 | $136.97 | 5,427 | $743K | 3.8% |
| 15 | $137.76 | 1,107 | $153K | 0.8% |
| 16 | $137.76 | 1,107 | $153K | 0.8% |
| Total | $133.77 avg | 145,830 | $19.5M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |